Abstract
(Abstracted from J Matern Fetal Neonatal Med 2017;30(11):1342–1346) Intrahepatic cholestasis of pregnancy (ICP) is associated with increased risk of adverse outcomes, including stillbirth, spontaneous preterm birth, and passage of meconium. Management of ICP patients consists of both controlling symptoms and minimizing fetal/neonatal risk for complications.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
